Using both our previously described whole-CFTR-locus NGS panel [4] to identify breakpoints and subsequent mRNA sequencing for the confirmation of in-tandem localization, we were able to characterize and reclassify the duplication as likely pathogenic, providing both families with conclusive diagnoses of CF. The gene discussed is CFTR; the disease is cystic fibrosis.